Our Product Pipeline
Xention is using its technology to develop a portfolio of drug candidates in areas of substantial commercial potential in a variety of disease areas by:
- Accelerating the discovery of ion channel active drugs with preferred modes of action and high activity and selectivity;
- Assembling the development expertise to rapidly progress programmes to clinical proof of concept; and
- Reducing attrition rates in the development process
